Page 2 - Les Meilleurs doctors pour votre Rééducation avec exosquelette - TOP 22 des médecins

Patthama Likitwittaya, M.D., physiatrist. Diplomate, Thai Board of Rehabilitation Medicine (2025). Rehabilitation Medicine Residency, Faculty of Medicine, Chulalongkorn University (2025). Doctor of Medicine, First-Class Honors, Thammasat University (2019).

Current role: Department of Rehabilitation Medicine, Somdech Phra Pinklao Hospital (July 2025–present). Prior internships: Queen Sirikit Naval Hospital (2019–2020). Songkhla Naval Base Hospital (2020–2021). Naval Hospital Bangkok (2021–2022).

Research: Principal investigator of “Effect of vibrotactile stimulation on gait in Parkinson’s disease and parkinsonism.” Presented at the Royal College of Physiatrists of Thailand (2025).

Advanced training: 29th TOPF Osteoporosis and Related Diseases Grand Round (Dec 2024). Pain management with Focus Shock Wave Piezo Technology (Jul 2024). 35th TASP Annual Scientific Meeting (Mar 2024). Academic and Midyear Conferences of the Royal College of Physiatrists of Thailand (2022). Good Clinical Practice and human subject protection training (Jun 2022).

Dr. Ornicha Thititagul (Dr. Faangkaow) is a geriatrician and lecturer in the Geriatric Medicine Division at Siriraj Hospital, Mahidol University. She practices at Siriraj Samut Sakhon Geriatric Healthcare Center and Siriraj Piyamaharajkarun Hospital.

Accreditations include: M.D. (Second Class Honors, 2017); Diplomate, Thai Board of Internal Medicine (2021); WHO‑SEARO ICOPE Master Trainer (2021). Additional credentials: Diplomate in Geriatric Medicine (2023); Diplomate, International Board of Lifestyle Medicine (2024).

Research highlights include: a randomized controlled trial on oral nutritional supplements in older adults (Geriatrics, 2024); PG‑SGA versus MNA in hepatocellular carcinoma (Support Care Cancer 33, 116, 2025); and Thailand’s first abacavir hypersensitivity case report (J Med Assoc Thai, 2021). She was on the host team and served as a moderator at the 10th Asian Conference of Frailty and Sarcopenia in 2024.